FTC Sues Units Of CVS Health , Cigna , And UnitedHealth For Allegedly Artificially Inflating Insulin Prices; FTC Case Does Not Name Insulin Drugmakers Eli Lilly, Novo Nordisk, And Sanofi , But Agency Reserves Right To Sue Later
FTC Sues Units Of CVS Health , Cigna , And UnitedHealth For Allegedly Artificially Inflating Insulin Prices; FTC Case Does Not Name Insulin Drugmakers Eli Lilly, Novo Nordisk, And Sanofi , But Agency Reserves Right To Sue Later
美國聯邦貿易委員會起訴西維斯健康、Cigna和聯合健康附屬單位，指控其漲價；聯邦貿易委員會的案件未點名胰島素製造商Eli Lilly、Novo Nordisk和賽諾菲，但保留隨後起訴的權利。
FTC Alleges Pharmacy Benefit Managers Systematically Excluded Cheaper Insulins In Exchange For Expensive, Highly Rebated Alternatives
聯邦貿易委員會（FTC）指控藥房效益管理員系統地在交易所中排除了更便宜的胰島素，以換取昂貴、高回扣的替代品
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。